SCHEMBL13748620

SCHEMBL13748620

C#Cc1cccc(NNC(=C)Nc2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.48
NPSR1 Q6W5P4 5/20 0.48
GAA P10253 4/20 0.48
ALDH1A1 P00352 3/20 0.48
TDP1 Q9NUW8 3/20 0.48
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
IDO1 P14902 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TP53 P04637 1/20 0.42
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HSP90AA1 P07900 1/20 0.41
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4039305 0.85 MAPT (0.57) MAPTNPSR1GAAALDH1A1TDP1
SCHEMBL4035224 0.85 MAPT (0.57) MAPTNPSR1GAAALDH1A1TDP1
SCHEMBL4037834 0.80 KMT2A (0.68) MAPTNPSR1GAAALDH1A1MEN1
SCHEMBL30080659 0.80 KMT2A (0.68) MAPTNPSR1GAAALDH1A1MEN1
SCHEMBL13748796 0.80 LCK (0.65) MAPTNPSR1GAAALDH1A1TDP1
SCHEMBL13748313 0.79 TEK (0.44) MAPTNPSR1GAAALDH1A1TDP1
SCHEMBL17936093 0.74 MAPT (0.74) MAPTMEN1KMT2AHTTRAB9A
SCHEMBL17818404 0.74 MAPT (0.70) MAPTMEN1KMT2AHTTRAB9A
SCHEMBL933875 0.72 PTPN1 (0.61) ALDH1A1IDO1
SCHEMBL29890941 0.72 PTPN1 (0.61) ALDH1A1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009100536-A1 INHIBITORS OF KINASE ACTIVITY WITH 1,2-DI-CYCLYL SUBSTITUTED ALKYNE STRUCTURES METHYLGENE INC. (CA) 2009-08-20 WO disclosed